"Ugh, I’m So Fat!" The Perfect Response Every Time You Hear This

FDA grants Orphan Drug Designation to Oncolytics' REOLYSIN for treatment of peritoneal cancer

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers.



from The Medical News http://ift.tt/1EdMYmU

Tian Ge, Xi He collaborate to develop new mobile health management platform

Tian Ge Interactive Holdings Limited, the largest "many-to-many" live social communities platform in China, announced that the Company has agreed to invest approximately RMB24 million (~USD$3.8 million) in exchange for approximately 34.47% equity interest in Hangzhou Xi He Technology Co., Ltd., a market leader in providing health management software to hospitals and physical check-up clinics in China, on a fully-diluted basis.



from The Medical News http://ift.tt/1AUyJT7

Global trends in health inequalities among young people related to income inequality

Health inequalities in young people have grown alongside socioeconomic disparities between the rich and poor.



from The Medical News http://ift.tt/1DDOuLx

TSRI researchers show how ABC transporters cause multidrug resistance

Cancer patients fear the possibility that one day their cells might start rendering many different chemotherapy regimens ineffective. This phenomenon, called multidrug resistance, leads to tumors that defy treatment.



from The Medical News http://ift.tt/1wPMYDu

New standardized approach for feeding infants in NICU improves growth of babies

A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner.



from The Medical News http://ift.tt/1EJ6M2c

MD Anderson scientists show why some brain cancer patients develop resistance to treatments

Scientists at The University of Texas MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments including radiation and the chemotherapy agent temozolomide.



from The Medical News http://ift.tt/1EJ6M2a